Simplex Trading
PBYI icon

Simplex Trading’s Puma Biotechnology PBYI Stock Holding History

Simplex Trading’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28K Hold
200
– – ﹤0.01% 8516
2025
Q4 		$1.19K Buy
+200
New +$1.06K ﹤0.01% 7987
2025
Q2 		– Sell
-2,100
Closed -$6K – 9469
2025
Q1 		$6K Sell
2,100
-100
-5% -$313 ﹤0.01% 7473
2024
Q4 		$6K Sell
2,200
-4,000
-65% -$11.6K ﹤0.01% 7520
2024
Q3 		$15K Sell
6,200
-1,100
-15% -$3.33K ﹤0.01% 6906
2024
Q2 		$23K Buy
7,300
+5,700
+356% +$25K ﹤0.01% 6778
2024
Q1 		$8K Sell
1,600
-18,100
-92% -$97.5K ﹤0.01% 7762
2023
Q4 		$85K Buy
19,700
+15,800
+405% +$52.3K ﹤0.01% 5549
2023
Q3 		$10K Sell
3,900
-11,700
-75% -$39.8K ﹤0.01% 7190
2023
Q2 		$55K Sell
15,600
-10,500
-40% -$32.8K ﹤0.01% 5752
2023
Q1 		$80K Buy
26,100
+15,900
+156% +$59.9K ﹤0.01% 5414
2022
Q4 		$43K Buy
+10,200
New +$35.2K ﹤0.01% 6060
2022
Q3 		– Sell
-400
Closed -$1K – 10632
2022
Q2 		$1K Sell
400
-5,500
-93% -$13.7K ﹤0.01% 9638
2022
Q1 		$16K Buy
5,900
+1,200
+26% +$3.1K ﹤0.01% 8472
2021
Q4 		$14K Sell
4,700
-3,600
-43% -$15.6K ﹤0.01% 8758
2021
Q3 		$77K Hold
8,300
– – ﹤0.01% 6978
2021
Q2 		$76K Buy
+8,300
New +$84.1K ﹤0.01% 7117
2021
Q1 		– Sell
-111
Closed -$113K – 9726
2020
Q4 		$113K Sell
111
-140
-56% -$1.42K ﹤0.01% 5323
2020
Q3 		$253K Sell
251
-19
-7% -$193 ﹤0.01% 3813
2020
Q2 		$281K Buy
270
+11
+4% +$114 ﹤0.01% 3605
2020
Q1 		$218K Sell
259
-310
-54% -$3.01K ﹤0.01% 3491
2019
Q4 		$497K Buy
569
+74
+15% +$613 ﹤0.01% 2765
2019
Q3 		$532K Buy
495
+447
+931% +$4.83K ﹤0.01% 2555
2019
Q2 		$61K Sell
48
-125
-72% -$2.88K ﹤0.01% 4690
2019
Q1 		$671K Sell
173
-231
-57% -$7.05K ﹤0.01% 2349
2018
Q4 		$822K Buy
404
+330
+446% +$9.9K ﹤0.01% 1791
2018
Q3 		$339K Sell
74
-63
-46% -$3.04K ﹤0.01% 3033
2018
Q2 		$810K Buy
137
+69
+101% +$4K ﹤0.01% 1979
2018
Q1 		$103K Sell
68
-35
-34% -$2.62K ﹤0.01% 1781
2017
Q4 		$37K Buy
103
+37
+56% +$4.14K ﹤0.01% 2719
2017
Q3 		$9K Sell
66
-463
-88% -$43.1K ﹤0.01% 3878
2017
Q2 		$171K Buy
529
+316
+148% +$17.7K 0.01% 1300
2017
Q1 		$103K Sell
213
-67
-24% -$2.44K ﹤0.01% 1727
2016
Q4 		$300K Sell
280
-126
-31% -$5.45K 0.02% 799
2016
Q3 		$35K Buy
406
+71
+21% +$3.59K ﹤0.01% 2427
2016
Q2 		$299K Buy
335
+162
+94% +$5.07K 0.02% 772
2016
Q1 		$931K Buy
173
+13
+8% +$587 0.07% 239
2015
Q4 		$490K Sell
160
-26
-14% -$2.04K 0.04% 445
2015
Q3 		$383K Buy
186
+109
+142% +$10.3K 0.03% 555
2015
Q2 		$179K Buy
77
+62
+413% +$11.2K 0.02% 857
2015
Q1 		$70K Sell
15
-74
-83% -$15.8K 0.01% 1320
2014
Q4 		$392K Buy
+89
New +$19.7K 0.05% 348

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Simplex Trading's PBYI Position: Q3 2024 in Review

Simplex Trading sold out of Puma Biotechnology (PBYI) in Q3 2024, closing a stake of 3,498 shares — an estimated $10.6K sold.

Simplex Trading first reported a position in PBYI in Q4 2014 and held it in 30 quarters. The position peaked at $1.29M in Q2 2017. 100 funds tracked by Wall St. Rank hold PBYI as of Q3 2024.

  • Simplex Trading reported no remaining Puma Biotechnology position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 3,498 Puma Biotechnology shares in Q3 2024, an estimated $10.6K.
  • Simplex Trading first reported a position in Puma Biotechnology in Q4 2014 and held it in 30 quarters.
  • Simplex Trading's Puma Biotechnology position peaked at $1.29M in Q2 2017.
  • 100 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.